CMS Medicare Drug Price Negotiations Yield $12B Savings on 15 High-Cost Medications
CMS announces $12 billion savings from Medicare drug price negotiations on 15 high-cost medications, effective 2027, enhancing Medicare Part D sustainability.
CMS Announces Significant 2027 Reductions on 15 High-Cost Medicare Drugs
CMS sets 2027 maximum fair prices for 15 high-cost Medicare drugs, cutting costs by up to 85% and saving $12 billion annually under Inflation Reduction Act measures.
Novo Nordisk Faces CMS Drug Price Cuts but New Indications Offer Growth Potential
Novo Nordisk's semaglutide drugs face significant Medicare price reductions under CMS negotiation rules starting 2027, but new indications could drive future revenue growth.
US Congress Advances Healthcare Legislation; FDA Launches Agentic AI; CMS Updates Payments
Overview of US Congressional healthcare legislation, FDA's AI modernization, CMS payment reforms, and key trade agreements influencing the insurance landscape in 2025.
Hospitals Sue HHS Over 340B Pilot Program Changes
Hospitals challenge HHS's 340B pilot shifting drug discounts to a rebate system, citing financial risks and regulatory concerns.
U.S. Prospective MFN Pricing Could Balance Drug Costs and Innovation
Explore how the U.S. prospective most-favored-nation (MFN) pricing strategy aims to lower drug prices while preserving pharmaceutical innovation and encouraging fair global contributions to R&D funding.
CMS Proposes 2027 Medicare Advantage Rule; Drug Price Negotiations Advance
Summary of recent CMS proposals affecting 2027 Medicare Advantage and Part D, plus updates on Medicare drug price negotiations impacting federal health programs.
Medicare Drug Price Negotiations Yield $12 Billion Savings on 15 Key Medications
New Medicare drug price negotiations under the Inflation Reduction Act cut costs for 15 major medications, saving Medicare $12 billion annually.
Medicare Drug Price Negotiations Cut Costs for 15 Key Medications
New Medicare drug price negotiations reduce government costs on 15 high-spend medications, including cancer and diabetes treatments, saving $12 billion annually.
Trump Administration Secures Medicare Drug Price Cuts for 15 Medications
The Trump administration finalizes agreements reducing Medicare prices for 15 drugs, aiming to save billions and impact Medicare Part D plans and drug affordability policies.